Bayesian Capital Management, LP Precigen, Inc. Transaction History

Bayesian Capital Management, LP

  • $838 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
BUY
$0.89 - $1.41 $10,057 - $15,933
11,300 New
11,300 $15,000
Q3 2022

Nov 14, 2022
SELL
$1.41 - $2.79 $7,755 - $15,345
-5,500 Reduced 35.26%
10,100 $21,000
Q2 2022

Aug 15, 2022
BUY
$1.15 - $2.53 $17,940 - $39,468
15,600 New
15,600 $21,000

Others Institutions Holding PGEN

# of Institutions
143
Shares Held
159M
Call Options Held
232K
Put Options Held
69K
View Full List

About PRECIGEN, INC.

PGEN Quotes by TradingView
  • Ticker PGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 208,150,000
  • Market Cap $187M
  • Description
  • Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...
More about PGEN
Track This Portfolio

Track Bayesian Capital Management, LP Portfolio

Follow Bayesian Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bayesian Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Bayesian Capital Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email